Yearbook of Cardiology 2017

Dev B Pahlajani MD FACC FSCAI FISE Chief of Interventional Cardiology, Breach Candy Hospital, Mumbai, Maharashtra, India Akshay Mehta MD DM Consultant Cardiologist, Nanavati Hospital Mumbai, Maharashtra, India

Section 1: Coronary Heart Disease



Critical Journal Review





Impact of the Timing of Metoprolol Administration During STEMI on Infarct Size and Ventricular Function
Outcomes in Women Better with Newer Generation Des
When is Rotational Angiography Superior to Conventional Singleplane Angiography for Planning Coronary Angioplasty?
Effects of Optimism and Gratitude on Physical Activity, Biomarkers, and Readmissions After an Acute Coronary Syndrome The Gratitude Research in Acute Coronary Events Study (GRACE study)
Impact of Ivabradine on Central Aortic Blood Pressure and Myocardial Perfusion in Patients With Stable Coronary Artery Disease
Survival After Varying Revascularization Strategies in Patients With ST-Segment Elevation Myocardial Infarction and Multivessel Coronary Artery Disease—A Pairwise and Network Meta-

Analysis
Effect of Supplemental Oxygen Exposure on Myocardial Injury in ST-elevation Myocardial Infarction
Medical Treatment and Revascularization Options in Patients With Type 2 Diabetes and Coronary Disease
Effect of Pre-Hospital Ticagrelor During the First 24 h After Primary Percutaneous Coronary Intervention in Patients With ST-Segment Elevation Myocardial Infarction The ATLANTIC-H24 Analysis
Successful Recanalization of Native Coronary Chronic Total Occlusion Is Not Associated With Improved Long-Term Survival
Comparison of Early Versus Delayed Blockers in Acute Coronary Syndromes and Effect on Outcomes
Prevention of Bleeding in Patients with Atrial Fibrillation Undergoing PCI
Drug Filled Polymer Free Stent Non-inferior to Conventional Drug Eluting Stent First-in-Human Evaluation of a Novel Polymer-Free Drug-Filled Stent: Angiographic, IVUS, OCT, and Clinical Outcomes From the RevElution Study
Emergency Percutaneous Coronary Intervention in Post-Cardiac Arrest Patients without ST Segment Elevation Pattern: Insights from the PROCAT II Registry
A Novel Score Predictive of Technical Failure During Percutaneous Coronary Revascularization for Chronic Total Occlusions
PCI or CABG or Both Together? Hybrid Coronary Revascularization for the Treatment of Multivessel Coronary Artery Disease
Is Percutaneous Coronary Intervention (PCI) a Viable Option In Perioperative Myocardial nfarction (PMI)? Percutaneous Intervention for Myocardial Infarction after Noncardiac Surgery
Pharmacodynamics Effects of Switching From Prasugrel to Ticagrelor: Results of Prospective Randomized SWAP 3 Study
Early Invasive Treatment for NSTEMI-ACS Reduces Hospital Stay and Recurrent Ischemia But Not Death and MI: Timing of Coronary Invasive Strategy in Non-ST-segment Elevation Acute Coronary Syndrome and Clinical Outcomes
Is Percutaneous Coronary Intervention Considered to be a Potential Alternative to Coronary Artery Bypass Grafting for Unprotected Left Main Coronary Artery Stenosis? Randomized Trial of Stents Versus Bypass Surgery for Left Main Coronary Artery Disease. 5-Year Outcomes of the PRECOMBAT Study
Is It Time for Percutaneous Coronary Intervention for all Lesions in STEMI? Randomized Trial of Complete Versus Lesion-Only Revascularization in Patients Undergoing Primary Percutaneous

Coronary Intervention for STEMI and Multivessel Disease. The CvLPRIT Trial
Does Operator Experience Play a Role in Outcomes after Left Main Percutaneous Coronary Intervention Impact of Operator Experience and Volume on Outcomes After Left Main Coronary Artery Percutaneous Coronary Intervention
Does Percutaneous Coronary Intervention improve Outcomes in a patient with Multi-vessel Disease and Concurrent Chronic Total Occlusion? Percutaneous Intervention for Concurrent Chronic Total Occlusions in Patients with STEMI The EXPLORE Trial
Dual Antiplatelet Therapy Versus Aspirin Monotherapy in Diabetics With Multivessel Disease Undergoing CABG
“When You Encounter Ectasia in Primary PCI”: Risk Factors and Outcomes in Patients With Ectatic Infarct-related Artery Who Underwent Primary Percutaneous Coronary Intervention After ST Elevated Myocardial Infarction
What is the Answer in Multivessel Disease? CABG or PCI? Long Term Mortality Revascularization In Nondiabetic Patients with Multivessel Disease
Early Angiography could reduce Bleeding Events in Patients with non ST Segment Elevation  Acute Coronary Syndrome Bleeding Events Before Coronary Angiography in Patients With Non ST Segment Elevation Acute Coronary Syndrome
When is the Right Time? Surgery post Coronary Drug Eluting Stent Implantation: Risk Associated With Surgery With 12 Months After Coronary Drug-Eluting Stent Implantation
Is Aspiration Thrombectomy “Really” Associated with Increased Risk for Stroke? The Risk for Stroke With Aspiration Thrombectomy: Procedure or Patient Related? Insights From a Meta-Analysis
Faster Drug Absorption, More Prompt and Potent Antiplatelet Effects: The New Crushed Prasugrel: Crushed Prasugrel Tablets in Patients With STEMI Undergoing Primary Percutaneous Coronary Intervention
Safety and Efficacy Benefits of DCS over BMS in Patients With High Risk Of Bleeding 2-Year Outcomes of High Bleeding Risk Patients After Polymer-Free Drug-Coated Stents
The EBC TWO Study (European Bifurcation Coronary TWO): A Randomized Comparison of Provisional T-Stenting Versus a Systematic 2 Stent Culotte Strategy in Large Caliber True

Bifurcations
Is Coronary Artery Bypass Graft Surgery Associated with Better Outcomes as Compared to Percutaneous Coronary Intervention? Percutaneous Coronary Angioplasty Versus Coronary Artery Bypass Grafting in Treatment of Unprotected Left Main Stenosis (Noble): A Prospective, Randomised, Open-label, Non-inferiority Trial
The Evergreen Debate: PCI Versus Surgery in Unprotected Left Main CAD Coronary Artery Bypass

Surgery Versus Drug-Eluting Stent Implantation for Left Main or Multivessel Coronary Artery Disease
Left Internal Mammary Artery Versus Coronary Stents: Impact on Downstream Coronary Stenoses and Conduit Patency
Repeat Revascularization more common after Percutaneous Coronary Intervention than after Coronary Artery Bypass Grafting Incidence, Characteristics, Predictors, and Outcomes of Repeat

Revascularization After Percutaneous Coronary Intervention and Coronary Artery Bypass Grafting The SYNTAX Trial at 5 Years
Biocompatible Durable Polymer Coated Des Non Inferior to Biodegradable Polymer Des Comparison of Durable-Polymer Zotarolimus-Eluting and Biodegradable-Polymer Biolimus-Eluting Coronary Stents in Patients with Coronary Artery Disease 3-Year Clinical Outcomes in the Randomized SORT OUT VI Trial
Is there an ideal Level of Platelet P2Y12 Receptor Inhibition in Patients Undergoing Percutaneous Coronary Intervention? “Window“ Analysis from the ADAPT-DES Study
Effect of Preoperative Aspirin Replacement With Enoxaparin in Patients Undergoing Primary Isolated on Pump CABG
Perioperative Cardiovascular Risk of Prior Coronary Stent Implantation Among Patients Undergoing Non Cardiac Surgery
A Randomized Comparison of Reservoir Based Polymer Free Amphilimus Eluting Stent Versus Everolimus Eluting Stent With Durable Polymer In Patients With Diabetes Mellitus
The Association of Previous Revascularization with In-hospital Outcomes in Acute Myocardial Infarction Patients
Post Hospital Outcomes of the Patients With Acute Myocardial Infarction With Cardiogenic Shock
Platelet Inhibition With Ticagrelor 60 mg Versus 90 mg Twice Daily in The Pegasus-TIMI 54 Trial
Impact of Access Site on Bleeding and Ischemic Effects in Patients With Nstemi Treated With Prasugrel
Sex Difference in Chest Pain After Implantation of Newer Generation Coronary Drug Elutng Stents
Refining Echo Techniques for Left Ventricular Thrombus Detection Post-Myocardial Infarction

Echocardiographic Algorithm for Post-Myocardial Infarction LV Thrombus: A Gatekeeper for Thrombus Evaluation by Delayed Enhancement CMR


 



Cardiology Currents





Biodegradable Polymers versus Durable Polymers: Has the Jury Returned?
High Sensitivity Troponins: Opportunities and Challenges
When and Which Antiplatelet Drug Loading before PCI in Stable IHD?
Fractional Flow Reserve Computed Tomography — Ready for Prime Time?
Myocardial Viability Testing — Why and How?
Serendipity from Noncardiac Imaging
A Chronic Total Occlusion is Known by the Company it Keeps!
Deferring Stenting in Primary PCI—What is the Last Word?
Left Main Disease, Who’s Baby is It Anyway?
Management of Stable Ischemic Heart Disease – Current Perspective
Dilemma – BMS or Des for Patients at High Bleeding Risk?
Dilemma – Non St Elevation Myocardial Infarction: When to Intervene?
Bioresorbable Scaffolds for Management of Coronary Bifurcation Lesions — Feasible?


 



Section 2: Noncoronary Heart Disease



Critical Journal Review





Causes of Death in Anticoagulated Patients With Atrial Fibrillation
Benefit of Vitamin K Antagonist Addition Anticoagulation Versus Antiplatelet or No Therapy In Patients Undergoing Bioprosthetic Valve Implantation: A Systematic Review and Meta-Analysis
Age is the Culprit! Late Outcomes of Transcatheter Aortic Valve Replacement in High-Risk Patients: The FRANCE-2 Registry
Importance of NOAC Optimum Dosing: Focus on ORBIT AF II Registry Off-Label Dosing of Non-Vitamin K Antagonist Oral Anticoagulants and Adverse Outcomes. The ORBIT-AF II Registry
Is Percutaneous Mitral Valve Plication Effective in Management of Severely Symptomatic, Obstructive Hypertrophic Cardiomyopathy Patients First Experience With Percutaneous Mitral Valve Plication as Primary Therapy for Symptomatic Obstructive Hypertrophic Cardiomyopathy
Oral anticoagulation or Aspirin—What is Better? Aspirin Instead of Oral Anticoagulants Prescription in Atrial Fibrillation Patients at Risk for Stroke
The Feminine Advantage: One Year Outcomes after TAVR Sex-Based Differences in Outcomes With Transcatheter Aortic Valve Therapy. TVT Registry From 2011 to 2014
Feasibility Trial of Percutaneous Repair and Replacement Mitral Regurgitation Percutaneous Direct Annuloplasty. Lessons From an Early Feasibility Trial


 



Cardiology Currents





Clearing Patients with Severe Aortic Stenosis for Non Cardiac Surgery
The Value of Calcium in a Stenotic Aortic Valve
Iron Therapy for Heart Failure—Intravenous or Oral?
Atrial Fibrillation in STEMI Poor Prognosis: Determinants of Prognosis in Atrial Fibrillation in Acute ST-Elevation Myocardial Infarction (STEMI) and Acute Coronary Syndrome (ACS) —

Arrhythmia or Comorbidities?
Which New Oral Anticoagulant for Which Patient?


 



Section 3: Preventive Cardiology



Critical Journal Review





Morning Home Blood Pressure is a Strong Predictor of Coronary Artery Disease: The HONEST Study
Statins for Prevention of Cardiovascular Events in a Low-risk Population with Low Ankle Brachial Index
Atherothrombotic Risk Stratification and Ezetimibe for Secondary Prevention
The Association between Alcohol Abuse and Cardiac Disease
Troponin Concentration Change at 1 year is Associated with Future Coronary Risk Independent of Cholesterol Lowering: High-Sensitivity Cardiac Troponin, Statin Therapy, and Risk of Coronary Heart Disease
Influenza Vaccine for Prevention of MI: Influenza Vaccine as a Coronary Intervention for Prevention of Myocardial Infarction
Are they Related: Social Relationships and Coronary Heart Disease? Loneliness and Social Isolation as Risk Factors for Coronary Heart Disease and Stroke: Systematic Review and Meta-Analysis of Longitudinal Observational Studies
Tracking Plaque Regression with Statins on CCTA: Effects of Statin Therapy on Progression of Mild Noncalcified Coronary Plaque Assessed by Serial Coronary Computed Tomography Angiography: A Multicenter Prospective Study
Importance of Intensive BP Control in Older Patients: Outcomes of Intensive Blood Pressure Lowering in Older Hypertensive Patients
The Primary Drivers Of Changes In Preventive Medical And Lifestyle Practices Amongst People Presenting With Suspected Coronary Artery Disease: Changes in Medical Therapy and Lifestyle After Anatomical or Functional Testing for Coronary Artery Disease
A New Weapon in the Prevention Armamentarium? Phosphodiesterase Type-5 Inhibitor Use in Type 2 Diabetes is Associated with a Reduction in All-cause Mortality
Pulse Pressure and Risk of Cardiovascular Events in Patients With Atherothrombosis


 



Cardiology Currents





Why Prevention is the Key to a Woman’s Heart?
Statins for Primary Prevention – Widening the Net in “Low-risk” People. Narrowing it in “High-risk” People




Index